Drug Profile
VS 411 - Vidasym
Alternative Names: VS-411 - VidasymLatest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Vidasym
- Class Vitamin D analogues
- Mechanism of Action Calcitonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammatory bowel diseases; Psoriasis
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in USA
- 28 Sep 2020 No recent reports of development identified for preclinical development in Psoriasis in USA
- 05 Aug 2016 Preclinical trials in Inflammatory bowel disease in USA (unspecified route)